ZFIN ID: ZDB-PUB-050623-9
The zebrafish retinol dehydrogenase, rdh1l, is essential for intestinal development and is regulated by the tumor suppressor adenomatous polyposis coli
Nadauld, L.D., Shelton, D.N., Chidester, S., Yost, H.J., and Jones, D.A.
Date: 2005
Source: The Journal of biological chemistry   280(34): 30490-30495 (Journal)
Registered Authors: Yost, H. Joseph
Keywords: none
MeSH Terms:
  • Adenomatous Polyposis Coli Protein/metabolism*
  • Alcohol Oxidoreductases/biosynthesis*
  • Alcohol Oxidoreductases/chemistry
  • Alcohol Oxidoreductases/metabolism
  • Alcohol Oxidoreductases/physiology*
  • Animals
  • Cell Differentiation
  • Gene Expression Regulation, Developmental
  • In Situ Hybridization
  • Intestines/embryology
  • Intestines/enzymology*
  • Intestines/metabolism
  • Mutation
  • Phenotype
  • RNA/metabolism
  • RNA, Messenger/metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tretinoin/metabolism*
  • Zebrafish
  • Zebrafish Proteins/biosynthesis*
  • Zebrafish Proteins/physiology*
PubMed: 15967793 Full text @ J. Biol. Chem.
Retinoic acid is a potent signaling molecule that plays important roles in multiple and diverse developmental processes. The contribution of retinoic acid to promoting the development and differentiation of the vertebrate intestine and the factors that regulate RA production in the gut remain poorly defined. Herein, we report that the novel retinol dehydrogenase, rdh1l, is required for proper gut development and differentiation. rdh1l is expressed ubiquitously during early development but becomes restricted to the gut by 3 days post fertilization. Knockdown of rdh1l results in a robust RA-deficient phenotype including lack of intestinal differentiation which can be rescued by the addition of exogenous retinoic acid. We report that APC mutant zebrafish harbor an RA-deficient phenotype including aberrant intestinal differentiation and that these mutants can be rescued by treatment with retinoic acid or injection of rdh1l mRNA. Further, we have found that while APC mutants are deficient in rdh1l expression, they harbor increased expression of raldh2 suggesting the control of RA production by APC is via RDH activity. These results provide genetic evidence that retinoic acid is required for vertebrate gut development and that the tumor suppressor APC controls the production of RA in the gut by regulating the expression of the retinol dehydrogenase, rdh1l.